Who is sponsoring NCT05819996?

NCT05819996 is sponsored by Purdue University.

What drugs are being tested in NCT05819996?

Interventions in NCT05819996: Environmental educational campaign.

What condition does NCT05819996 study?

NCT05819996 studies Vapors; Inhalation, Cancer, Volatile Organic Compounds.

Is NCT05819996 still recruiting?

NCT05819996 is currently recruiting now. Last updated 18 March 2025.

Last reviewed 2025-03-18 · How we verify

NCT05819996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Addressing Tetrachloroethylene Exposure in an Impacted Community

Recruiting now NA Last updated 18 March 2025

What this trial tests

NA trial testing Environmental educational campaign in Vapors; Inhalation in 510 participants. Currently enrolling.

Timeline

17 February 2023

Primary endpoint
31 May 2028

31 May 2028

Quick facts

Lead sponsor	Purdue University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	510
Start date	17 February 2023
Primary completion	31 May 2028
Estimated completion	31 May 2028
Sites	1 location across United States

Drugs / interventions tested

Environmental educational campaign

Conditions studied

Vapors; Inhalation — all drugs for Vapors; Inhalation →
Cancer — all drugs for Cancer →
Volatile Organic Compounds — all drugs for Volatile Organic Compounds →

Sponsor

Purdue University

Who can join

Adults 18 to 99, any sex, with Vapors; Inhalation or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Groundwater in Martinsville, IN, is contaminated by volatile organic compounds (VOCs), tetrachloroethylene (PCE) and trichloroethylene (TCE). Indoor air in some residential and commercial buildings is also contaminated with PCE and TCE. This study is being conducted to better understand the impact of low-level exposures to these compounds on community members' health. Data collected in this study will be used to help the community identify a course of action.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Purdue University trials

Trials by the same sponsor.

NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05819996 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Purdue University
Last refreshed: 18 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05819996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing